Highlights and Quick Summary
- Other current assets for the quarter ending March 31, 2022 was $8.88 Million (a 27.16% increase compared to previous quarter)
- Year-over-year quarterly Other current assets increased by 57.35%
- Annual Other current assets for 2021 was $6.98 Million (a -41.93% decrease from previous year)
- Annual Other current assets for 2020 was $12 Million (a 237.36% increase from previous year)
- Annual Other current assets for 2019 was $3.57 Million (a 165.25% increase from previous year)
Visit stockrow.com/PHAS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Other current assets of PhaseBio Pharmaceuticals
Most recent Other current assetsof PHAS including historical data for past 10 years.Interactive Chart of Other current assets of PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals Other current assets for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $8.88 | – | – | – | – |
| 2021 | $6.98 | $8.88 | $5.64 | $11.19 | $6.98 |
| 2020 | $12.03 | $10.6 | $10.72 | $12.2 | $12.03 |
| 2019 | – | – | – | $3.57 | $3.57 |
| 2018 | – | – | – | – | $1.34 |
| 2017 | – | – | – | – | $0.34 |
| 2016 | – | – | – | – | $0.17 |
Business Profile of PhaseBio Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology